抗生素使用与医院内起病艰难梭菌感染的生态学关联
该研究基于549家美国急性病医院2006–2012年数据,采用横断面与时间序列分析评估医院层面抗生素使用量与医院内起病艰难梭菌感染(HO-CDI)的关联。结果显示总抗生素使用、氟喹诺酮类及第三、四代头孢菌素使用量增加与HO-CDI升高相关,而上述药物使用量下降与HO-CDI下降相关。
要点
- 总抗生素使用每增加50 DOT/1000 PD,HO-CDI增加4.4%。
- 第三、四代头孢菌素每增加10 DOT/1000 PD,HO-CDI分别增加2.1%和2.9%。
- 总抗生素使用下降≥30%的6家医院HO-CDI下降33%。
核心结论
- 在生态学层面,总抗生素使用、氟喹诺酮类及第三、四代头孢菌素使用量下降均与HO-CDI率下降相关。
研究设计与样本
- 横断面与时间序列生态学分析,纳入549家美国急性病医院2006–2012年数据,采用多变量广义估计方程模型校正患者与医院特征。
主要发现
- 2006–2012年未校正HO-CDI年率为7.3/10 000患者日(95%CI 7.1–7.5),总抗生素使用为811 DOT/1000患者日(95%CI 803–820)。
- 横断面分析中,总抗生素使用每增加50 DOT/1000患者日,HO-CDI增加4.4%。
- 第三、四代头孢菌素或碳青霉烯类每增加10 DOT/1000患者日,HO-CDI分别增加2.1%和2.9%。
- 氟喹诺酮类或第三、四代头孢菌素使用下降≥20%的医院,HO-CDI分别下降8%和13%。
临床怎么用
- 提示医院层面减少总抗生素、氟喹诺酮类及第三、四代头孢菌素使用可能有助于降低HO-CDI率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unnecessary antibiotic use (AU) contributes to increased rates of Clostridioides difficile infection (CDI). The impact of antibiotic restriction on hospital-onset CDI (HO-CDI) has not been assessed in a large group of US acute care hospitals (ACHs). METHODS: We examined cross-sectional and temporal associations between rates of hospital-level AU and HO-CDI using data from 549 ACHs. HO-CDI was defined as a discharge with a secondary International Classification of Diseases, Ninth Revision, Clinical Modification code for CDI (008.45), and treatment with metronidazole or oral vancomycin > 3 days after admission. Analyses were performed using multivariable generalized estimating equation models adjusting for patient and hospital characteristics. RESULTS: During 2006-2012, the unadjusted annual rates of HO-CDI and total AU were 7.3 per 10 000 patient-days (PD) (95% confidence interval [CI], 7.1-7.5) and 811 days of therapy (DOT)/1000 PD (95% CI, 803-820), respectively. In the cross-sectional analysis, for every 50 DOT/1000 PD increase in total AU, there was a 4.4% increase in HO-CDI. For every 10 DOT/1000 PD increase in use of third- and fourth-generation cephalosporins or carbapenems, there was a 2.1% and 2.9% increase in HO-CDI, respectively. In the time-series analysis, the 6 ACHs with a ≥30% decrease in total AU had a 33% decrease in HO-CDI (rate ratio, 0.67 [95% CI, .47-.96]); ACHs with a ≥20% decrease in fluoroquinolone or third- and fourth-generation cephalosporin use had a corresponding decrease in HO-CDI of 8% and 13%, respectively. CONCLUSIONS: At an ecologic level, reductions in total AU, use of fluoroquinolones, and use of third- and fourth-generation cephalosporins were each associated with decreased HO-CDI rates.
引用
- Kazakova SV, Baggs J, McDonald LC, et al. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis. Clin Infect Dis. 2020. PMID: 30820545. doi:10.1093/cid/ciz169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。